Rare Diseases policy
This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases
Please find below some recent news of relevance for the life sciences sector as well as press releases and publications published by us.
This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases